Dermira Profile

27.42
USD 0.36  1.33%
23.34Last Month High 27.51 
27.09Trading Day  High 27.86 

Sale by David Cohen of 600 shares of Dermira

Dermira Inc insider trading alert for sale of common stock by David Cohen, the corporate stakeholder, on December 5, 2017. This event was filed by Dermira Inc with SEC on 2017-12-05. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Dermira Summary

Dermira Inc (DERM) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 62 people. Dermira is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with current market capitalization of 1.13 B. Dermira Inc conducts business under Healthcare sector and is part of Biotechnology industry. This company has 41.67 M outstanding shares of which 5.09 M shares are currently shorted by private and institutional investors with about 12.21 trading days to cover. Dermira currently holds about 662.88 M in cash with (71.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 15.91.
Check Dermira Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected Dermira Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Dermira Against Markets

Risk Adjusted
Performance Score (0 to 100)
17 
Chance of
< 25% 
Dermira, Inc., a biopharmaceutical company, engages in identifying, developing, and commercializing therapies to enhance the lives of patients with dermatologic diseases primarily in the United States. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameDermira Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationCALIFORNIA, U.S.A
Business Address275 Middlefield Road, Suite 150, Menlo Park, CA 94025, United States
ExchangeNASDAQ
CIK Number01557883.0
CUSIP24983L104
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.dermira.com
Contact Number650 421 7200
CurrencyUSD - US Dollar

Recommendations

Dermira Analyst Recommendations
Target PriceAdvice# of Analysts
44.33Strong Buy3Odds
Dermira Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Dermira Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

Dermira Earnings Estimates
Dermira Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate